|
CN1850823A
|
|
Quinolone compound containing oximino, and its preparing method and use
|
|
CN1817863A
|
|
3-substituted 1,2,3.4-tetrahydro-quinazine derivative, its synthesis and use
|
|
CN1891704A
|
|
Dipetidase tetrainhibitor, and its preparing method and use
|
|
CN1861560A
|
|
Carboxylic acid derivant, its preparation process and pharmaceutical composition
|
|
CN1680304A
|
|
Lingshui alcohol with anti-cancer activity, its preparation and use
|
|
CN1680235A
|
|
Preparation and use of compounds i.e., falcarindiol as inhibitor of protein-tyrosine-phosphatase 1B
|
|
CN1680238A
|
|
Preparation and use of compounds i.e., 1,3-dihydroxy-5-alkyl benzene as inhibitor of protein-tyrosine-phosphatase 1B
|
|
CN1472318A
|
|
Expression and purification of soluble SARS virus nucleocapsid protein
|
|
CN1552690A
|
|
Benzyl ethylene quininate derivatives, their preparations and uses
|
|
CN1405168A
|
|
Tert-butoxy carbonyl dihydro artemisinin, preparation method and drug composition thereof
|
|
CN1429552A
|
|
Medical use of 11,11'-dideoxy wotixilin
|
|
CN1406585A
|
|
Medicinal composition for viral myocarditis
|
|
CN1406582A
|
|
Anti-cancer salvithin injection
|
|
CN1405164A
|
|
Corter pseudolaricis acid derivatives, preparation method and use thereof
|
|
CN1345724A
|
|
Indolylpiperidine compound and preparation process and use thereof
|
